"Same price at every dose" has become one of 2026's loudest marketing claims. It's a genuinely different billing philosophy, and depending on your titration path, it's either a quiet subsidy in your favor or a premium you're paying for someone else's high dose. Here's the arithmetic.
Key Takeaways
- Tiered plans charge more as your dose rises; flat plans charge one price from 0.25mg to maximum.
- Flat pricing wins for patients who titrate to mid/high doses and stay — exactly the typical trajectory.
- Tiered pricing can win for confirmed low-dose responders and maintenance patients at 0.5–1.0mg.
- The dose-tier jump is where tiered plans bite: some programs step up sharply at higher tiers — always ask for the full dose-price schedule before starting.
The Two Billing Philosophies
Tiered pricing tracks the medication cost: more milligrams, more money — sometimes gently, sometimes with a cliff (a known example in our tracker: sublingual programs that run ~$229/month at starter doses and step to $399/month once you reach 7.5mg+). Flat pricing averages it out: everyone pays the same, meaning early low-dose months effectively subsidize later high-dose months — your own later months, if you stay.
The Worked Example
Take a standard semaglutide titration: months 1–2 at low dose, months 3–4 mid, months 5–12 at a full maintenance dose.
| Plan type | Months 1–4 | Months 5–12 | Year-one total |
|---|---|---|---|
| Flat $179/mo | $716 | $1,432 | $2,148 |
| Tiered $149 low / $199 mid / $279 high | $696 | $2,232 | $2,928 |
| Flat annual-commit $99/mo | $396 | $792 | $1,188 |
The pattern generalizes: the faster and higher you titrate, the more flat pricing favors you. The tiered plan only wins if you never leave the low tiers.
Who Should Prefer Tiered
Two honest cases. Confirmed low-dose responders — if you've already demonstrated that 0.5mg holds your appetite and weight, paying a flat rate calibrated to average users overcharges you. Maintenance steppers-down — patients deliberately reducing to a minimal maintenance dose can shop the low tiers aggressively. In both cases you know your dose destiny; flat pricing exists precisely for the people who don't yet.
Questions Before You Sign Either
- For tiered: the complete dose-price schedule, in writing, including the top tier. Cliffs hide at the top.
- For flat: what's the commitment term, and the medical-exit policy?
- For both: does the price include clinical follow-up and dose-change handling, or are those billed events?
The Flat-Price Field Right Now
Telos Rx — Semaglutide
Compounded semaglutide — from $49/mo on 12-month plans
Flat pricing regardless of dose, with month-to-month through annual commitment tiers.
Compounded medications are not FDA-approved.
Visit Telos Rx Paid linkTelos Rx — Tirzepatide
Compounded tirzepatide — from $49/mo on 12-month plans
$199 month-to-month down to $49/mo annual, flat at every dose, FSA/HSA accepted.
Compounded medications are not FDA-approved.
Visit Telos Rx Paid linkSHED
Sublingual drops — sema ~$229/mo (rises to $399/mo at 7.5mg+ doses)
Sublingual compounded semaglutide. Note the dose-tier jump: pricing moves to $399/mo once you titrate to 7.5mg or above.
Compounded medications are not FDA-approved.
Visit SHED Paid linkOne sentence to carry out: if you don't yet know your maintenance dose, flat pricing is insurance you'll probably use; if you do know it and it's low, tiered is your discount.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.